Guangyao Group and Xipa Group signed a strategic cooperation agreement to jointly promote the development

Tianshan News (Reporter Hei Hongwei reported) On the afternoon of August 4, Guangzhou Pharmaceutical Group Co., Ltd. and Xinjiang Xipa Technology Industry Group Co., Ltd. signed a strategic cooperation agreement. , Pharmaceutical distribution services, brand marketing, and the integration of traditional Chinese medicine and pharmaceutical industries in traditional Chinese medicine.

On the afternoon of August 4, Guangzhou Pharmaceutical Group Co., Ltd. and Xinjiang Xipa Technology Industry Group Co., Ltd. signed a strategic cooperation agreement. Pomegranate cloud/Xinjiang Daily reporter Hei Hongwei Photo

Guangyao Group is the first company in the world to enter the top 500 in the world with Chinese medicine. It has formed four main business segments of Danan Pharmaceutical, Da Health, Big Commercial, and Da Medical Medicine. The top of the list is the largest pharmaceutical company group in the country.

"The complementarity between the two parties is very complementary, and the sharing of resources can be strongly united. Xinjiang's business environment is very good. Guangyao Group will carry out long -term, stable and in -depth cooperative relationships with Xipa Group. The social responsibility of the industry has promoted the innovation and upgrading of Xinjiang's pharmaceutical industry. "Zhang Chunbo, deputy general manager of Guangyao Group.

Xipa Group's pharmaceutical and health industry sector represents NVC -Kang Pharmaceutical Co., Ltd., one of the largest Chinese medicine ethnic pharmaceutical companies in Xinjiang. Its Sipyi Gingival is the largest product with the largest sales volume of Xinjiang Chinese Medicine National Medicine. Xiphe Group has established the embryonicity of the traditional Chinese medicine health industry, forming a full industrial chain layout of medicinal materials management, slices processing, Chinese patent medicine and large health products production and research and development, and offline marketing. It is reported that during the "Fourteenth Five -Year Plan" period of Xipa Group, the planting of millions of acres of traditional Chinese medicinal materials and industrial projects such as the "Belt and Road" Chinese medicinal and technological industrial park were planned.

Xu Zhixue, chairman of Xipa Group, introduced that this cooperation will focus on technological exchanges and production cooperation in the aspects of Chinese medicinal materials planting, the supply of Chinese medicine decoction, and the research and development of chemicals and drugs. The development of employment and related industrial chains helps rural revitalization. Xiphe Group will work with Guangyao Group to study some practical problems in the pharmaceutical industry, and study the needs of technology, markets, and consumers. I hope to graft the excellent experience of Guangyao Group through this cooperation. Get together to protect the national medicine in Xinjiang and inherit it.

- END -